Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis

Dementia and Geriatric Cognitive Disorders

Volumn 26, Issue 6, 2008, Pages 547-555

  Waragai, M ^a,e   Mizumura, S ^b   Yamada, T ^c   Matsuda, H ^d  

^a JR Tokyo General Hospital   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

^d SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^e TOHOKU UNIVERSITY   (Japan)

Author keywords

Dementia; Easy Z score imaging system; SPECT

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; IODOBENZYLGUANIDINE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN SCINTISCANNING; CINGULATE GYRUS; CONTROL GROUP; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; MIXED DEPRESSION AND DEMENTIA; MULTIINFARCT DEMENTIA; PARIETAL LOBE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

3-IODOBENZYLGUANIDINE; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CYSTEINE; DEMENTIA; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEWY BODY DISEASE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORGANOTECHNETIUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 57249108813     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000180280     Document Type: Article

References (28)

1. Ashburner J, Friston KJ: Voxel-based morphometry - the methods. Neuroimage 2000;11:805-821.
2. Frith CD, Friston KJ, Ashburner J, et al: Principles and methods; in Frackowiak RSJ, Friston KJ, Frith CD, Dolan RJ, Mazziotta JC (eds): Human Brain Function, ed 1. San Diego, Academic Press, 1997, pp 3-159.
3. Minoshima S, Berger KL, Lee KS, et al: An automated method for rotational correction and centering of three-dimensional functional brain images. J Nucl Med 1992;33:1579-1585.
4. Minoshima S, Koeppe RA, Mintun MA, et al: Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med 1993;34:322-329.
5. Minoshima S, Koeppe RA, Frey KA, et al: Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994;35:1528-1537.
6. Matsuda H, Mizumura S, Soma T, et al: Conversion of brain SPECT images between different collimators and reconstruction processes for analysis using statistical parametric mapping. Nucl Med Commun 2004;25:67-74.
7. Kanetaka H, Matsuda H, Asada T, et al: Effects of partial volume correction on discrimination between very early Alzheimer's dementia and controls using brain perfusion SPECT. Eur J Nucl Med Mol Imaging 2004;31:975-980.
8. Matsuda H, Mizumura S, Nagao T, et al: Automated discrimination between very early Alzheimer's disease and controls using an easy Z-score imaging system for multicenter brain perfusion SPECT. AJNR Am J Neuroradiol 2007;28:731-736.
9. Matsuda H: Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT. J Nucl Med 2007;48:1289-1300.
10. Waragai M, Yamada T, Matsuda H: Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early diagnosis of neurodegenerative diseases. J Neurol Sci 2007;260:57-64.
11. Johnson KA, Jones K, Holman BL, et al: Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998;50:1563-1571.
12. Kogure D, Matsuda H, Ohnishi T, et al: Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000;41:1155-1162.
13. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
14. Román GC, Tatemichi TK, Erkinjuntti T, et al: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
15. Rosen HJ, Hartikainen KM, Jagust W, et al: Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology 2002;58:1608-1615.
16. McKeith IG, Dickson DW, Lowe J, et al: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-1872.
17. 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease. J Neurol Sci 2006;240:15-19.
18. 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 2006;66:1850-1854.
19. Minoshima S, Giordani B, Berent S, et al: Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94
20. Ishii K, Imamura T, Sasaki M, et al: Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 1998;51:125-130.
21. Lobotesis K, Fenwick JD, Phipps A, et al: Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001;56:643-649.
22. Minoshima S, Foster NL, Sima AA, et al: Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001;50:358-365.
23. Shimizu S, Hanyu H, Kanetaka H, et al: Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT. Dement Geriatr Cogn Disord 2005;20:25-30.
24. Nakano S, Asada T, Yamashita F, et al: Relationship between antisocial behavior and regional cerebral blood flow in frontotemporal dementia. Neuroimage 2006;32:301-306.
25. 99mTc HmPAO SPECT data. J Neurol Neurosurg Psychiatry 2000;69:661-663.
26. Bonte FJ, Harris TS, Roney CA, et al: Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign. J Nucl Med 2004;45:771-774.
27. Irie F, Fitzpatrick AL, Lopez OL, et al: Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE ε4: the Cardiovascular Health Study Cognition Study. Arch Neurol 2008;65:89-93.
28. Gold G, Giannakopoulos P, Herrmann FR, et al: Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain 2007;130:2830-2836.